doi:10.19982/j.issn.1000-6621.20250320

Abstract

CLC Number:

References 21

[1]	Gallagher CS, Ginsburg GS, Musick A. Biobanking with genetics shapes precision medicine and global health. Nat Rev Genet, 2025, 26(3): 191-202. doi:10.1038/s41576-024-00794-y. pmid: 39567741
[2]	Kozlakidis Z, Hong Cheong I, Wei Q. Supporting the scientific advancement from pathogenic microorganisms biobank. Biosafety and Health, 2022, 4(5): 283-284. doi:10.1016/j.bsheal.2022.09.002.
[3]	Sayers EW, Cavanaugh M, Clark K, et al. GenBank. Nucleic Acids Res, 2021, 49(D1): D92-D96. doi:10.1093/nar/gkaa1023. pmid: 33196830
[4]	O'Cathail C, Ahamed A, Burgin J, et al. The European Nucleotide Archive in 2024. Nucleic Acids Res, 2025, 53(D1):D49-D55. doi:10.1093/nar/gkae975. pmid: 39558171
[5]	Fukuda A, Kodama Y, Mashima J, et al. DDBJ update: streamlining submission and access of human data. Nucleic Acids Res, 2021, 49(D1):D71-D75. doi:10.1093/nar/gkaa982. pmid: 33156332
[6]	Bahcall OG. UK Biobank-a new era in genomic medicine. Nat Rev Genet, 2018, 19(12):737. doi:10.1038/s41576-018-0065-3. pmid: 30348997
[7]	Precision Medicine Initiative (PMI) Working Group. The Precision Medicine Initiative Cohort Program[R/OL]. [2025-03-25]. https://www.precisionmedicine.center/the-precision-medicine-initiative-cohort-program/ .
[8]	Conroy MC, Lacey B, Bešević J, et al. UK Biobank: a globally important resource for cancer research. Br J Cancer, 2023, 128(4):519-527. doi:10.1038/s41416-022-02053-5.
[9]	UK Biobank. UK Biobank's Wrap Up 2024[EB/OL]. (2024-12-20) [2025-04-03]. https://www.ukbiobank.ac.uk/news/uk-biobanks-wrap-up-2024/ .
[10]	刘克新, 郑琳, 王莹, 等. 生物样本库的现状及研究进展. 中国病案, 2014, 15(9):32-34. doi:10.3969/j.issn.1672-2566.2014.09.016.
[11]	中华人民共和国科学技术部. 关于印发十二五生物技术发展规划的通知. 国科发社〔2011〕588号. 2011-11-14.
[12]	中华人民共和国生物安全法. 2020-10-17.
[13]	中华人民共和国国务院办公厅. 国务院办公厅关于印发“十四五”国民健康规划的通知. 国办发〔2022〕11号. 2022-04-27.
[14]	胥义, 郭宁, 杨国梁, 等. 生物样本库建设中的低温生物学. 中国科学:生命科学, 2023, 53(7): 1021-1034. doi:10.1360/SSV-2022-0171.
[15]	郑君, 李义庭, 李鑫. 生物样本库知情同意研究. 中国医学伦理学, 2025, 38(1):72-77. doi:10.12026/j.issn.1001-8565.2025.01.11.
[16]	郜恒骏, 杜莉利. 中国生物样本库迈进NSBAAA的崭新时代. 中国科学:生命科学, 2024, 54(6):971-975. doi:10.1360/SSV-2023-0157.
[17]	World Health Organization. Global Tuberculosis Report 2024. Geneva: World Health Organization, 2024.
[18]	黄晓洁, 杜伟丽, 赵宏, 等. 结核病病理诊断质控蜡块的制备及其性能评估. 中国防痨杂志, 2025, 47(10): xxx-xxx. doi:10.19982/j.issn.1000-6621.20250181
[19]	黄予晴, 孙祖钰, 刘毅, 等. 玻璃化冻存新技术处理肺癌手术标本用于构建类器官的探索. 中国防痨杂志, 2025, 47(10): 1261-1267. doi:10.19982/j.issn.1000-6621.20250180.
[20]	刘东鑫, 魏强, 刘剑君. 中国结核病菌种资源库建设与应用. 中国防痨杂志, 2025, 47(10): 1242-1248. doi:10.19982/j.issn.1000-6621.20250214.
[21]	陶婧, 谢梦娇, 宋杨, 等. 人类粪便样本采集与保存研究进展. 中国防痨杂志, 2025, 47(10): 1378-1385. doi:10.19982/j.issn.1000-6621.20250215.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 21

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Dongxin, Wei Qiang, Liu Jianjun. The construction and application of Chinese Tuberculosis Strains Resource Bank [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1242-1248.
[2]	Feng Yinping, Zhang Zunjing, Cai Qiujie, Wang Xiaomeng, Ma Yan, Liu Zhongda, Gao Lei. Exploring diagnostic and therapeutic approaches for latent tuberculosis infection based on the theory of hidden pathogen (Fu Xie) [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1249-1253.
[3]	Huang Xiaojie, Du Weili, Zhao Hong, Su Dan, Liu Zichen, Zhao Yingli, Liu Yi, Che Nanying. Preparation and performance evaluation of quality control paraffin blocks for the pathological diagnosis of tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1254-1260.
[4]	Yan Tianxin, Ma Wenbin, Wang Jia, Li Tao, Zhang Hui, Zhao Yanlin, Qu Yan, Luo Xiaofeng. Analysis of the factors influencing adherence and treatment outcomes among pulmonary tuberculosis patients with comorbidities in China from 2010 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1268-1278.
[5]	Jiang Xiujing, Zhong Qin, Yi Jie, He Fei, Chen Xiaohong. A study on the association between tuberculosis history and depressive status in Chinese population aged 45 years and older [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1279-1288.
[6]	Ding Yuanlu, Xiao Wenjing, Tao Fangfang, Feng Wei, Wang Ye, Rao Lixin, Shen Xin, Chen Jian, Chen Jing. Analysis of reported incidence trends of pulmonary tuberculosis in Shanghai, China, 2009—2023, using a Joinpoint regression model [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1289-1299.
[7]	Xie Yuanqi, Song Lin, Yao Yanhua, Cai Lili. A survey and analysis of quality of life among young and middle-aged pulmonary tuberculosis patients and their spouses [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1300-1310.
[8]	Chu Guangyan, Li Ting, Yu Jianing, He Di, Zhang Kun, Hou Shaoying, Yan Shichun. Building and evaluating a predictive model for secondary pulmonary tuberculosis based on Random Forest model [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1311-1317.
[9]	Zhang Weile, Li Dongxu, Wang Liwei, Su Min, Gao Yulong. Analysis on influencing factors of the use of intelligent health management tools among patients with pulmonary tuberculosis in Inner Mongolia Autonomous Region in 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1318-1325.
[10]	Shi Xiaojing, Wang Xin, Guo Jianhua, Zhao Qingran, Wang Yuhan. Research on influencing factors of preventive treatment of latent tuberculosis infection based on thematic analysis:Taking Shijiazhuang City as an example [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1326-1332.
[11]	Wang Liping, Zhang Pei, Qin Xiaohua, Zhou Xin, Jiang Caihua, Li Xuezheng. Distribution and drug resistance characteristics of pathogens in patients with pulmonary tuberculosis and non-pulmonary tuberculosis complicated with lower respiratory tract infections [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1333-1341.
[12]	Zhang Xin, Zheng Huiqiang, Liu Yuan, Wu Xia, Wang Haidong, Tan Xiaowen. The auxiliary diagnostic value of Mycobacterium tuberculosis-specific cytokines combined with common laboratory indicators in early extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1342-1349.
[13]	Chen Lulu, Luo Mengxing, Zou Xin, Yao Xin, Xu Yuyan, Liu Zhonghua. Analysis of clinical characteristics and anti-tuberculosis treatment effectiveness of elderly patients with pulmonary tuberculosis complicated with anemia [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1350-1357.
[14]	Zhang Fan, Chen Muxing, Chen Xiaohong, Nie Wenjuan, Chu Naihui. Characteristics and correlation of immune function and nutritional status in patients with pulmonary tuberculosis combined with extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1358-1364.
[15]	Wang Hangxing, Zhang Ning, Liu Xiaoqing, Kang Lin. Global development trends and hotspots of researches on elderly tuberculosis, 2000—2025: a visualized bibliometric analysis [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1365-1377.